A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

The decision comes only a week after it approved a new round of messenger RNA shots from Pfizer and Moderna, which both ...

Friday, the FDA granted Emergency Use Authorization to Novavax Inc.’s (NASDAQ:NVAX) COVID-19 Vaccine, Adjuvanted (2024-2025 ...

The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday ... 1 is the parent variant of KP.2. The FDA in June asked vaccine makers to create shots that target the ...

The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID ... The FDA’s approval of the vaccine comes as the federal agency announced ...

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...

The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the ...

Which brings us to today. The US Food and Drug Administration (FDA) has just approved an updated version of Novavax’s ...

The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID ... 19 vaccine option," said Peter Marks, director of the FDA's ...

Also Read: FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax’s Shot. “Our updated vaccine targets JN.1, the ‘parent strain’ of currently circulating ...

The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID ...